Assessment of the efficiency of Brentuximab Vedotin in patients with pulmonary Hodgkin Lymphoma by the mean of neutrophil to lymphocyte ratioGokhan Erdem a , Nuri Karadurmus b, Sukru Ozaydin b , Ibrahim Demirci c, Bilgin Bahadir Basgoz d, Ismail Ertürk b, Birol Yıldız b,Ramzan Ocal e, Fikret Arpaci aa Liv Hospital, Department of Medical Oncology, Ankara, Turkey
b University of Health Sciences, Gulhane Training and Research Hospital, Department of Medical Oncology, Ankara, Turkey
c University of Health Sciences, Gulhane Training and Research Hospital, Department of Endocrinology, Ankara, Turkey
d University of Health Sciences, Gulhane Training and Research Hospital, Department of Internal Medicine, Ankara, Turkey
e Gazi University, Department of Hematology, Ankara, TurkeyDOI: 10.1016/j.jons.2017.10.006 Sayfalar: 29 - 34 1362 Viewed.